(Q36418149)

14 August 2017

title

Abrupt discontinuation of psychotropic drugs following confirmation of pregnancy: a risky practice (English)

1 reference

14 August 2017

1

Adrienne Einarson

1 reference

14 August 2017

publication date

1 November 2005

1 reference

Journal of Obstetrics and Gynaecology Canada

14 August 2017

published in

1 reference

14 August 2017

volume

27

1 reference

14 August 2017

issue

11

1 reference

14 August 2017

page(s)

1019-1022

1 reference

Psychiatric disorders during pregnancy

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930500-X

7 January 2021

The safety of antidepressant use in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930500-X

7 January 2021

Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930500-X

7 January 2021

Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930500-X

7 January 2021

Safety of haloperidol and penfluridol in pregnancy: a multicenter, prospective, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930500-X

7 January 2021

Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930500-X

7 January 2021

Treatment of epilepsy in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930500-X

7 January 2021

Increased rate of major malformations in offspring exposed to valproate during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930500-X

7 January 2021

Lamotrigine and the risk of malformations in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930500-X

7 January 2021

Safety of the newer antiepileptic drug oxcarbazepine during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930500-X

7 January 2021

Gabapentin exposure in human pregnancy: results from the Gabapentin Pregnancy Registry

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930500-X

7 January 2021

Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930500-X

7 January 2021

Moclobemide in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930500-X

7 January 2021

Use of antidepressants by pregnant women: evaluation of perception of risk, efficacy of evidence based counseling and determinants of decision making

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930500-X

7 January 2021

Psychotropic medication in pregnancy: ethical aspects and clinical management

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930500-X

7 January 2021

Mania induced by lorazepam withdrawal: a report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930500-X

7 January 2021

Strategies for switching from conventional antipsychotic drugs or risperidone to olanzapine.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930500-X

7 January 2021

Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930500-X

7 January 2021

Newer anticonvulsants: comparative review of drug interactions and adverse effects.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930500-X

7 January 2021

Exacerbation of psychosis after discontinuation of carbamazepine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930500-X

7 January 2021

Changes in arrhythmia profile and heart rate variability during abrupt withdrawal of antiepileptic drugs. Implications for sudden death

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930500-X

7 January 2021

Abrupt lithium discontinuation in manic-depressive patients

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930500-X

7 January 2021

Encephalopathy associated with rapid decrease of high levels of lithium

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930500-X

7 January 2021

Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930500-X

7 January 2021

Heterocyclic antidepressant, monoamine oxidase inhibitor and neuroleptic withdrawal phenomena

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930500-X

7 January 2021

10.1016/S1701-2163(16)30500-X

Identifiers

DOI

1 reference

release_fjxaleubr5cuzno6qlwvrkhwhm

14 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fjxaleubr5cuzno6qlwvrkhwhm

24 November 2022

mapped directly with Wikidata item

1 reference